Objectives: Examine the cause of local recurrence (LR) and patient survival (S) following abdominoperineal resection (APR) and anterior resection (AR) for rectal carcinoma and the effect of introduction of total mesorectal excision (TME) on APR. Methods: A total of 608 patients underwent surgery for rectal cancer in Leeds from 1986 to 1997. CRM status and follow-up data of local recurrence and patient survival were available for 561 patients, of whom 190 underwent APR (32.4%) and 371 AR (63.3%). Also, a retrospective study of pathologic images of 93 specimens of rectal carcinoma. Results: Patients undergoing APR had a higher LR and lower survival (LR, 22.3% versus 13.5%, P ϭ 0.002; S, 52.3% versus 65.8%, P ϭ 0.003) than AR. LR free rates were lower in the APR group and cancer specific survival was lowered (LR, 66% versus 77%, log rank P ϭ 0.03; S, 48% versus 59%, log rank P ϭ 0.02). Morphometry: total area of surgically removed tissue outside the muscularis propria was smaller in APR specimens (n ϭ 27) than AR specimens (n ϭ 66) (P Ͻ 0.0001). Linear dimensions of transverse slices of tissue containing tumor, median posterior, and lateral measurements were smaller (P Ͻ 0.05) in the APR than the AR group. APR specimens with histologically positive CRM (n ϭ 11) had a smaller area of tissue outside the muscularis propria (P ϭ 0.04) compared with the CRM-negative APR specimens (n ϭ 16). Incidence of CRM involvement in the APR group (41%) was higher than in the AR group (12%) (P ϭ 0.006) in the 1997 to 2000 cohort.
Similar results (36% and 22%) were found in the 1986 to 1997 cohort (P ϭ 0.002). Conclusions: Patients treated by APR have a higher rate of CRM involvement, a higher LR, and poorer prognosis than AR. The frequency of CRM involvement for APR has not diminished with TME. CRM involvement in the APR specimens is related to the removal of less tissue at the level of the tumor in an APR. Where possible, a more radical operation should be considered for all low rectal cancer tumors. T otal mesorectal excision (TME) involves sharp dissection in the plane that separates the visceral mesorectal fascia from the parietal pelvic fascia. Surgical techniques aimed at TME and removal of tissue, including the rectal carcinoma as a "tumor package," [1] [2] [3] have been widely adopted, with improved patient outcome. For example, in a Swedish study involving surgical training, a local recurrence rate of 6% is reported in patients who underwent TME compared with 14% and 15% in the control groups (P Ͻ 0.0001). 4 In a national Norwegian audit involving 3319 new patients, the technique of TME was compared with conventional surgery. The observed local recurrence rate for patients undergoing a curative resection was 6% in the group treated by TME and 12% in the conventional surgery group, while the 4-year survival rate was 73% after TME and 60% after conventional surgery. 5 The large multicenter trial coordinated by the Dutch Colo-Rectal Cancer Study Group has used TME as the standard surgical procedure in examining the benefits of short-course preoperative radiotherapy in patients undergoing curative excision. 6 Early published indications (24 month follow-up) from the Dutch study are that TME plus preoperative radiotherapy (RT) is associated with a lower local recurrence rate (2.4%) than TME alone (8.2%) in patients who underwent macroscopically complete local resection. 7 Recently presented data show that these have risen to 5.8% and 11.4% at 4.83 years median follow up (van de Velde C, personal communication). The rates of local recurrence in the APR group were 9.3% and 14%. Preoperative short-course RT is considered a safe procedure in patients treated with TME surgery, despite a slight increase in complications when compared with TME surgery only. 8 Abdominoperineal resections (APRs) have been associated with high local recurrence compared with anterior resections (ARs). 3 Possible reasons include higher incidence of inadequate excision in APR, or that lymph node involvement may follow a different pattern in low rectal carcinomas. In a unit that pioneered TME, a series of 136 operations for carcinoma in the lower third of the rectum (below 5 cm from the anal verge) included 31 APR excisions (23%), with considerably higher 6-year local recurrence in the APR group than the corresponding AR group (33% versus 1% for patients who underwent curative procedures). 3 One of the aims of our study was to investigate the local recurrence rates and survival for patients who had undergone APR and AR procedures over the 12-year period 1986 to 1997, to assess the local effect of a change to TME and specifically its impact on APR. The impact of this change on local recurrence and survival by operating surgeon has been reported previously. 9 The mesorectum is the visceral mesentery surrounding the rectum and is covered by a layer of visceral fascia. Distally, the mesorectum tapers to reveal the muscle of the internal anal sphincter, and the "holy plane" of perimesorectal dissection advocated by Heald ends in the intersphincteric plane between internal and external sphincters. 10 In TME this smooth muscle tube is used for colo-anal anastomosis, but in cases of high rectal carcinoma the mesorectum may be transected 4 and mesorectal excision would not be total. The technique of TME allows dissection down to the pelvic floor, thus facilitating low anastomosis and sphincter-preservation as well as the visualization and preservation of nerves. The introduction of TME has resulted in a significant reduction in the rate of APR for rectal carcinoma, from being the "gold standard" procedure for much of the 20th Century to being necessary in perhaps 15% of patients. 2 In the Stockholm TME project, 4 there was a significantly lower proportion of APR in the TME group (27%) compared with the non-TME groups (55% and 60%).
Assessment of the surgical excision specimen following TME includes examination of the circumferential resection margin (CRM) for tumor involvement, which has been associated with increased local recurrence and lower patient survival, 9, 11 This was demonstrated in an analysis of the Norwegian Cancer Registry (n ϭ 686), which showed 22% local recurrence in CRMϩ cases (margin Յ1 mm) compared with 5% recurrence in CRM-negative cases. 12 Similar data have emerged from the Dutch TME/TME and radiotherapy trial, 13 the only difference being their claim that a 2-mm margin also indicated a higher risk. Assessment of the surgical excision specimen includes macroscopic assessment of completeness of resection, and overall recurrence rates at 2-year follow-up were found to be worse in the group with an incomplete mesorectum (P ϭ 0.01). 14 In patients with a negative CRM, the overall recurrence rate was increased in the group with incomplete mesorectum (28.6% versus 14.9%, P ϭ 0.03), hence assessment of completeness of the mesorectum by macroscopic examination is considered to have additional value in patients without CRM involvement. Abdominoperineal excisions were particularly poorly excised, with only 34% of cases showing a complete excision compared with 73% of anterior resections. 14 However, this study assessed the whole of the rectal excision and did not separate the quality of the mesorectal and anal canal dissections, making it impossible to determine the relative importance of each individual dissection as the cause of the increased local recurrence rate in APRs.
In view of the documented difference in local recurrence and quality of excision between APR and AR cases, we designed a study using morphometry to compare the macroscopic specimens following AR and APR procedures to identify the frequency of involvement of the CRM and reasons for an increased risk of involvement. It is our our standard laboratory practice and subsequently the national recommendation of the United Kingdom Royal College of Pathologists (http://www.rcpath.org/index.php?PageIDϭ229) to leave the bowel intact at the level of the tumor during fixation, thus allowing serial slicing of the fixed specimen and preservation of the circumferential margin. This has several advantages as it allows direct comparison with magnetic resonance imaging and effective assessment of the anterior CRM that would otherwise be destroyed by the opening process. Photography of the whole transverse slices is routine, and digital images taken from 1997 to 2000 provided an archive for a retrospective study of cases of primary rectal carcinoma by image analysis. The results obtained by morphometry were used to characterize the differences between the APR and AR specimens, and between the CRM-positive and CRM-negative specimens.
PATIENTS AND METHODS

Patient Outcome in the Cohort of 1986 -1997
Between January 1, 1986 and December 31, 1997, 608 resection specimens of rectal adenocarcinoma from Leeds hospitals were received in the department of histopathology at the Leeds General Infirmary. Clinical data recorded up to the end of 1998 or death of the patient was collected by a surgical research fellow (C.P.M.). The notes were reviewed and, in cases where there was inadequate hospital follow-up prior to 1998, the cancer registry or patient's general practitioner was contacted for additional information.
For the purpose of this study, local recurrence was defined as any recurrence within the pelvis provided it was proven by one of the following: 1) positive histology; 2) diagnostic imaging evidence in conjunction with a raised CEA; and 3) macroscopic evidence of tumor recurrence at relaparotomy.
Patients who died of noncancer-related illness were censored from further analysis from the time of death. The log-rank test was used to determine the significance of survival or cumulative risk of local recurrence differences between the different patient groups.
Prior to the analysis of recurrence and survival, the initial study group of 608 patients (342 males and 266 females) was reduced to 586 cases as follow-up data could not be obtained on 22 cases. A further 25 (4.3%) of the 586 patients received preoperative radiotherapy and were excluded from the study, leaving 561 patients, of whom 181 underwent APR and 355 underwent AR. Seventy patients (11.9%) received adjuvant chemotherapy, but there were no significant associations between these therapies and any particular surgical subgroup ( 2 tests, P ϭ 0.6 and P ϭ 0.95, respectively). Similarly, within the follow-up group, there were no associations between surgical subgroup (APR or AR) and particular Dukes' stages, T stages, or N stages ( 2 tests, P ϭ 0.9, P ϭ 0.8, and P ϭ 0.7, respectively), or between proportions of palliative cases and surgical subgroup ( 2 , P ϭ 0.8). The proportion of cases in each tumor T stage in the 1986 to 1997 cohort was similar to the distribution in the 1997 to 2000 group (Fig. 1 ). Palliative cases were those operations where the surgeon thought there was definite evidence of metastatic disease outside the surgical field at operation. Overall, 488 (83.3%) of these cases were considered to be potentially curative resections and 98 (16.7%) palliative. Palliative APRs were 31 of 181 (17.1%) and palliative ARs 53 of 355 (14.9%). Ten of 31 palliative APRs (32.2%) and 12 of 53 palliative ARs (22.6%) developed local recurrence, values that match the overall frequency of CRM positivity.
Morphometry on Cases From 1997-2000 Selection of Cases
Specimens excised for primary rectal carcinoma from 1997 to 2000 were studied retrospectively using images stored on the i-Base digital database (Ilkley, W. Yorks, UK). Of 152 cases of rectal carcinoma identified, 93 specimens following potentially curative TME were included in the study. Exclusion criteria included cases where adequate images were not available (n ϭ 26), curative resection was not attempted due to extent of disease (n ϭ 17), recurrence following previous surgery (n ϭ 7), and standard operating procedure violations (n ϭ 7) mostly related to longitudinal opening of bowel at the level of the tumor. In 2 cases, previous radiotherapy or chemoradiotherapy had obliterated identifiable tumor, and inclusion in the morphometric study was considered inappropriate as accurate measurements could not be performed. Of the 93 cases included in the study, 27 (29%) had undergone APR, of whom 19 (70%) had undergone preoperative radiotherapy according to the local protocol where APR patients are usually referred for shortcourse Swedish-style preoperative radiotherapy. Three of these patients had received chemoradiotherapy. Of the 66 patients undergoing AR, 18 had preoperative radiotherapy (27%), of whom one had chemoradiotherapy. Analysis by the 2 test showed that the AR and APR groups had a similar tumor stage distribution (P ϭ 0.9) by the TNM categorization ( Fig. 1 ), and the majority (73% and 74%) of cases in each group were stage pT3.
Morphometry
Digital images of specimens excised for rectal carcinoma are routinely taken at the time of specimen dissection. Specimen preparation includes painting the resection margin with india ink before fixation, and serial slicing of the specimen at 3 to 5 mm intervals at the level of the tumor as previously described, 15 keeping the circumference intact. In each case, the digital image of a single transverse slice that demonstrated tumor closest to the CRM was chosen for study. The dimensions and areas to be measured were traced manually on the digital image of the transverse slice of rectum (Fig. 2 ), and precise measurements were obtained using the Leica Q5001W image analyzer. Where anatomy was distorted by tumor, an estimate of the expected site of the muscularis propria was made. Assessment of the area of tissue was made by subtraction to give total area of tissue (not including the lumen) and area of tissue outside the muscularis propria.
Statistics
Each measurement was made in duplicate. The standard deviation (SD), 95% confidence limits for each group, and coefficient of variation (CV) as an indication of overall reproducibility (Table 1) were assessed by calculating the standard deviation from the difference between the duplicates by the formulae SD ϭ variance Variance ϭ (difference between duplicates) 2 2n Coeficient of variation (CV) ϭ (SD/mean) ϫ 100%
Most sets of data (grouped according to type of resection, CRM positivity, and gender) showed nonparametric distribution by the Kolmogorov test (P ϭ 0.1); therefore, the Mann-Whitney U test, 2 test and the Fisher exact test were performed using Microsoft Excel spreadsheets with Astute.
Clinical and Pathology Data
Details of circumferential margin involvement ascertained histologically were obtained from the pathology reports. Tumor distance to the CRM of less than or equal to 1 mm represented positivity. 11, 16 The type of surgery (APR versus AR) in each case was available from the request form, specimen description, and photograph. The presence of locally advanced disease was usually documented on the request form, and liaison with the surgical teams helped exclude cases where complete excision of the rectal carcinoma had not been attempted.
RESULTS
Survival and Local Recurrence
There was a significant difference in both local recurrence rate (23.8% versus 13.5%: P ϭ 0.002) and cancer-specific 5-year survival (52.3% versus 65.8%: P ϭ 0.003) between the APR and AR groups ( Table 2) , with the poorer prognosis in patients who had undergone APR. The cumulative proportion of patients without local recurrence was lower (66% versus 77%) in the APR group (log rank, P ϭ 0.026) and the proportion of patients surviving was lower (48% versus 59%) in the APR group (log rank, P ϭ 0.023) ( Fig. 3 ).
Morphometry
The measurements made on the slice showing closest proximity to the CRM were grouped according to type of surgery (Table 3) , CRM involvement (Table 3) , and the patient's gender.
The APR group (n ϭ 27) had a smaller area of surgically excised tissue outside the muscularis propria (P Ͻ 0.0001) and smaller total area of tissue (P ϭ 0.0005) than the AR group (n ϭ 66). In addition, the following linear measurements were significantly smaller in the APR than AR groups: posterior, left and right lateral measurements, and macroscopic measurement of the distance of tumor to closest circumferential margin (Table 3 ).
In the APR specimens, there was a smaller area of tissue outside the muscularis propria in the CRMϩ (n ϭ 11) compared with the CRM-negative (n ϭ 16) subset (P ϭ 0.04). As expected, the distance of tumor to resection margin measured macroscopically was significantly smaller in the CRMϩ subset.
There was no significant difference (P Ͼ 0.05) between the left and right lateral measurements in all specimens (n ϭ 93) or in the subgroups separated according to type of surgery and CRM positivity. The measured dimensions showed no significant difference between men and women in the AR subset (45 male, 21 female) or in the APR subset (21 male, 6 female) (data not shown), and only one gender difference (left lateral measurement, P ϭ 0.03) when all cases were compared (66 male, 27 female). The significance of this single difference is doubtful, especially as it was identified in only one of the lateral measurements.
Circumferential Margin Involvement
In the 1997 to 2000 patient cohort, the CRM positivity in the APR group (41%) was considerably higher than in the AR group (12%) (P ϭ 0.006). This is similar to the findings in the 1986 to 1997 cohort in which the CRM involvement was higher in the APR group (35%) than the AR group (22%) (P ϭ 0.002).
The rate of CRM involvement in APR and AR specimens was compared over the 3 time periods 1986 to 1989, 1990 to 1993, and 1994 to 1997 ( Table 4 ). The latter 2 periods correspond approximately to the phased introduction of TME as a matter of routine practice.
DISCUSSION
We found that the patients in the 1986 to 1997 cohort who had undergone an APR for rectal carcinoma had an increased local recurrence and poor survival compared with patients who had AR, in keeping with other published results. 3 The rate of local recurrence described in our series of 23.8% in our APR cases is thought to be due to the time scale of the series 1986 to 1997 and the fact that all operations within our institution were included and not surgically selected "curative" cases. Also, TME was only practiced from 1994 onwards. Maturing trials such as the Dutch TME trial of curative excisions also report relatively high rates of local recurrence at 5 years in the TME with APR group that did not receive radiotherapy of 14% (van de Velde C, final results of the Dutch TME trial; personal communication, February 2004). FIGURE 3 . Absence of local recurrence and cancer-specific survival by operation type (1986 -1997) . The high rates of local recurrence of APRs could be explained by a number of factors either singly or in combination. APR may be associated with a different pattern of lymphatic spread, which is not included in the "tumor package" excised by TME, or inadequate surgical resection may occur in a higher proportion of patients. Lymphatic spread to the iliac or obturator nodes occurs and removal of these nodes is reported as a determinant of local recurrence. 17 Inadequate excision appears to be the major factor determining outcome. In both the 1986 to 1997 cohort (n ϭ 586) and the 1997 to 2000 group (n ϭ 93), the patients who underwent APR had a significantly higher incidence of cir- Annals of Surgery • Volume 242, Number 1, July 2005 Modern Abdominoperineal Excision cumferential margin involvement, which is associated with both local recurrence and poor survival. 9, 11, 12, 14, 16 Our data thus suggest that inadequate local tumor excision is a major factor in the higher local recurrence and higher mortality in patients who have APR compared with those who have AR. The use of radiotherapy was infrequent (4.3%) in the former group but became routine for APR in the latter group (70%). This did not change the frequency of CRM-positive cases in the latter group. In a large trial, the effects of short course radiotherapy have been found not to downstage the tumor, 18 either in relationship to the stage of the tumor or the frequency of involvement of the CRM or distal resection margin, and in the Dutch study there is no benefit at 5 years on local recurrence or survival in the low rectal cancers at 0 to 5 cm (van de Velde C, final results of the Dutch TME trial; personal communication, February 2004) and would be unlikely to affect our results. The distribution of tumor stage within the APR and AR groups was similar for both patient cohorts (P ϭ 0.8 and 0.9) ( Fig. 1 ) and the majority were TNM stage pT3. The APR group had a greater depth of invasion 5 mm versus 3 mm (P ϭ 0.006), suggesting these were on average slightly bigger tumors; however, it would not be possible to avoid this bias as bigger tumors would tend to undergo an APR as sphincter saving would not be attempted. This does not, however, reduce the importance of the description of the smaller volume of tissue found in the APR group due to the local anatomy. The extent of tumor spread in itself is therefore unlikely to account for the increased CRM involvement, increased local recurrence, and poor survival in the APR group. Bearing in mind the tapering of the mesorectum toward the levators (Gray's Anatomy, 10 shown in Fig. 4A, B) . It is important for surgeons to understand it is likely that there is less tissue for the carcinoma to traverse before involving the surgical plane of resection in the low mesorectum and anal canal.
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The results of digital image morphometry show that in APR specimens there is less tissue to excise at the level of maximal invasion of the tumor, which would predispose to CRM involvement except in the very early stages. The area of tissue outside the muscularis propria in the transverse slice with the greatest degree of tumor spread is significantly smaller in APR than AR resection specimens. This is also the case in the CRM-positive APR compared with the CRMnegative APR specimens. Thus, while APR specimens may have a greater frequency on incomplete/poor mesorectal excisions above the tumor, 14 they also have a major problem at the height of the tumor demonstrated by the higher rate of CRM positivity.
It is recognized that, particularly following radiotherapy, the presence of fibrosis may make macroscopic assessment of tumor inaccurate when digital images are examined by morphometry, but most of the dimensions measured were of soft tissue other than tumor, with estimation of the previous site of muscularis propria where this was obscured by tumor or fibrosis.
There is the potential of using morphometry for exploring differences between individual patients and for developing clinicopathologic correlations. The amount of soft tissue between the muscularis propria and the CRM may be related to such factors as tumor site and size, patient body mass, degree of cachexia, and idiosyncrasies of the bony pelvis, including those attributable to gender (although no significant gender-related differences were discovered in our morphometric study); it may also be determined by quality of surgery. While recognizing the variation in tissue volume between individuals and the need to establish the normal range, measurements made by morphometry may be useful as a further method of auditing the quality of rectal cancer surgery in addition to the subjective criteria developed for the MRC CR07 and MRC CLASICC studies (MRC CR07 and MRC CLASICC Trial protocol) that was adopted and recently validated by the Dutch TME study. 14 Distal margins were accurately measured in this study. Although usually involved in less than 1% to 2% of cases as against the average 27% involvement of the CRM, the measurement of the distal margin is still important. This has been performed accurately in the following national and international trials that used the Leeds protocol of the MRC CLA-SICC trial, MRC CR07, National Cancer Research Institute Mercury trial, and the Dutch short course radiotherapy trial.
No difficulties have been reported in these studies and involvement rates are identical to other studies not using such a protocol. It should be emphasized that, if the tumor is more than 3 to 4 cm away from the distal margin, then opening the distal rectum to gain access to the area of the tumor is permissible as long as the site of the tumor is maintained intact. In practice, it is easy to measure the distance either by inserting a narrow measuring probe or using a digit to palpate the lower edge of the tumor in a way analogous to the approach used by surgeons clinically. To our knowledge, there have been no issues raised with this approach by pathologists who will have reported over 4300 patients in these trials.
It has been shown that preoperative magnetic resonance imaging (MRI) can define the mesorectal fascia and its proximity to the tumor 19, 20 and thereby help identify the expected TME resection margin. This should be extended to early pT1/ pT2 low rectal cancers with the possible addition of endorectal ultrasound. The identification of the proximity of the expected surgical CRM to the tumor in the low rectum is an important challenge to the radiologist to predict the likelihood of complete excision. We must, however, reiterate that pT3 low rectal cancers are unlikely to be completely excised by surgery, and either wider surgical excision, by removing the levators en bloc with the anal sphincters, a reduction in size of the tumor by preoperative radiotherapy or radiochemotherapy or both is required. Current guidelines in the United States from the National Cancer Institute 21 suggest that stage pT3 or greater and node-positive cases should be treated by postoperative chemoradiotherapy. In the future, these decisions should be informed by the site of the tumor, the CRM status, the type of operation planned, and evidence for the relative efficacy of preoperative versus postoperative therapy. In Europe, there is a growing move to accurate MRI and preoperative chemoradiotherapy.
There is evidence to suggest that the APR may have changed over the last half century. The original description by Miles 22 describes the abdominal dissection being performed down to the levator ani muscles, which were not incised at this point. The perineal dissection was then started, and he described "the removal of the coccyx and the removal of the levator ani by dividing them as far outwards as their origin from the 'white line' so as to include the lateral zone of spread." His description in 1910 confirms his perineal approach to the levators and he stated "these muscles are divided as far outwards as their origin from the pelvic wall." 23 The perineal approach and the wider excision of the levators are different from the current technique of following the mesorectal fascia down to the levators. The original approach of Miles would result in more tissue being excised in the low rectum and might lead to a lower rate of CRM involvement. There is also the suggestion of different approaches to the APR operation in different countries. In Sweden, some surgeons excise the anus and levator muscles from below with the patient lying prone (Holm T, personal communication), an altogether different approach to the current standard British or Dutch APR operation. This mainly perineal approach results in a completely different resection specimen with more tissue removed and a surgical resection margin much farther away from the muscularis propria and the sphincters (Fig. 4C, D) . The levator muscles are included in the specimen with their natural relationships intact. Removal of the coccyx improves the access to the levator plane and facilitates the wider operation and is routinely performed by Dr. Holm in Stockholm. It is not an absolute prerequisite of this type of operation and can be omitted, but the surgical difficulty may be increased. A randomized trial of removal versus retention has not been performed. The resulting perineal deficit is covered by surgical flaps. This operation should be considered in all low rectal pT3 tumors. The greater access of the perineal approach should reduce the frequency of perforation of the specimen and, in our experience, the common problem of the surgical margin entering the muscle wall low in the rectum.
There is still a role for consideration for preoperative chemoradiotherapy in some patients. Anterior tumors, those with extensive spread or nodal spread outside the resection area, and poorly differentiated or mucoid tumors should be considered for such therapy. In combination with a more radical operation, this should lead to improved outcomes.
Changes to the treatment of low rectal cancer are urgently required to achieve the lower rates of involvement of the CRM that are now obtained following mesorectal excision for high and mid rectal excisions. This should greatly improve local recurrence rates and 5-year survival in patients with low rectal cancers.
